News

News

Hikma continues strong 2020 performance and updates full year guidance

News

News

Hikma provides update on status of ANDA for generic Advair Diskus®

News

News

Hikma launches Icosapent Ethyl Capsules

Our impact

Every day, our medicines are used by approximately 13 million people. The impact we have on people's lives is important, positive and far-reaching.

#OwnYour Career @Hikma

#OwnYour Career @Hikma

Watch this video to hear Karim explain what it's like working in Technical Operations at our Cherry Hill, NJ site.

Case study

Case study

Our support and impact; improving patient’s access to ritonavir

Insight

Insight

Kept out of reach - tackling the enduring challenge of access to medicine

Update

Update

Hikma update regarding COVID-19

Find out more

Who we are. We make high quality medicines and make them accessible to the people that need them.

Corporate social responsibility

Corporate social responsibility

Hikma launches employee matching donation campaign to support local US food banks and pantries

Find out more

Find out more

Our commitment to sustainability

Find out more

Find out more

We develop, manufacture and market nearly 700 quality branded and non-branded generic medicines worldwide.